Gollob Jared
Chief Medical Officer
Gollob Jared has filed 4 SEC Form 4 filings (24 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Mar 4, 2026.
On the most recent filing, Gollob Jared is listed as Chief Medical Officer at Kymera Therapeutics, Inc. Inside the rolling window, Gollob Jared reported no open-market purchases and 5 open-market sales totaling $9.1M in KYMR. The largest disclosed transaction in the window is a sale of 49,307 KYMR shares on Dec 8, 2025, worth $4.4M.
Companies traded
Other insiders at KYMR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Gollob Jared made?
Gollob Jared has filed 4 SEC Form 4 filings (24 transaction rows) across 1 company since 2025.
Which companies does Gollob Jared trade?
Gollob Jared has filed SEC Form 4 disclosures for 1 company, including KYMR.
When was Gollob Jared's most recent SEC Form 4 filing?
Gollob Jared's most recent SEC Form 4 filing on Tracefour is dated Mar 4, 2026.
What is Gollob Jared's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Gollob Jared is listed as Chief Medical Officer.
What is Gollob Jared's total buy and sell value in the current window?
Inside the rolling retention window, Gollob Jared bought $0 and sold $9.1M based on SEC Form 4 filings.
What was Gollob Jared's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 49,307 KYMR shares on 2025-12-08, worth $4.4M, per SEC Form 4 filings.